FDA Inspection 1097891 — St Marks Outpatient Surgery
The FDA completed an inspection of St Marks Outpatient Surgery on July 18, 2019 in Salt Lake City, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 18, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Salt Lake City, UT (United States)